Production logistics of 177Lu for radionuclide therapy

Atkins, 1995, Sn-117m (4+) DTPA for palliation of painful osseous metastases, J. Nucl. Med., 36, 725

Bishayee, 2000, Marrow-sparing effects of 117mSn(4+) diethylenetriaminepentaacetic acid for radionuclide therapy of bone cancer, J. Nucl. Med., 40, 2043

Chakraborty, 2002, 177Lu–labeled polyaminophonates as potential agents for bone pain palliation, Nucl. Med. Commun., 23, 67, 10.1097/00006231-200201000-00011

Das, 2000, 188Re-Ethylene Dicysteine, Nucl. Med. Commun., 21, 939, 10.1097/00006231-200010000-00008

Das, 2002, 177Lu–labeled cyclic polyaminophonates as potential agents for bone pain palliation, Appl. Radiat. Isot., 57, 177, 10.1016/S0969-8043(02)00104-5

De Jong, 1998, Internalization of radiolabelled [DTPA0] octreotide and [DTPA0, Tyr3] octreotide, Nucl. Med. Commun., 19, 283, 10.1097/00006231-199803000-00013

Delaloye, 1995, Radiolabeled monoclonal antibodies in tumor imaging and therapy, Eur. J. Nucl. Med., 22, 571, 10.1007/BF00817285

Deutsch, 1993, Radiation Synovectomy revisited, Eur. J. Nucl. Med., 20, 1113, 10.1007/BF00173494

Ehrhardt, 1998, Reactor-produced radionuclides at the University of Missouri research reactor, Appl. Radiat. Isot., 49, 295, 10.1016/S0969-8043(97)00038-9

Ercan, 2000, Therapeutic radiopharmaceuticals, Curr. Pharmaceut. Des., 6, 1085, 10.2174/1381612003399833

Firestone, R., 1996. In: Shirley, V.S. (Eds.), Table of isotopes, 8th Edition. Wiley, New York.

Fritzberg, A.R., Gustavson, L.M., Hylarides, M.D., Reno, J.M., 1995. In: Weiner, D.B., Williams, M.V. (Eds.), Chemical and Stuctural Approaches to Rational Drug Design. CRC Press, Boca Raton, FL, p. 125.

Grazman, 1988, 105Rh as a potential radiotherapeutic agent, Appl. Radiat. Isot., 39, 257, 10.1016/0883-2889(88)90181-5

Goeckeler, 1987, Skeletal localisation of samarium-153 chelates, J. Nucl. Med., 28, 495

Jhu, 1998, Tumor pretargeting for radioimmunodetection and radioimmunotherapy, J. Nucl. Med., 39, 65

Kamioski, 1994, 188Re generator for biomedical applications, Radiochim. Acta., 65, 39

Ketring, 1987, 153Sm-EDTMP and 186Re-HEDP as bone therapeutic radiopharmaceuticals, Nucl. Med. Biol., 14, 223

Knapp, F.F., Ambrose, K.R., Beets, A.L., Luo, H., McPherson, D.W., Mirzadeh, S., 1995. Nuclear medicine program progress report for quarter ending September 30, 1995, Oak Ridge National Laboratory, pp. 6–16.

Liu, 2001, 90Y and 177Lu labeling of a DOTA-conjugated vitronectin receptor antagonist useful for tumor therapy, Bioconjug. Chem., 12, 559, 10.1021/bc000146n

Ma, 1996, Production of radiolanthanides and radiotherapy research at MURR, J. Radioanal. Nucl. Chem. Articles, 206, 119, 10.1007/BF02040048

Mausner, 1993, Selection of radionuclides for radioimmunotherapy, Med. Phys., 20, 503, 10.1118/1.597045

Mausner, 1998, Radionuclide development at BNL for nuclear medicine therapy, Appl. Radiat. Isot., 49, 285, 10.1016/S0969-8043(97)00040-7

Meredith, 1996, Intraperitonial radioimmunotherapy of ovarian cancer with lutetium-177-CC49, J. Nucl. Med., 37, 1491

Mumper, 1992, Neutron activated holmium-166- Poly (l-Lactic acid) microspheres, J. Nucl. Med., 32, 2139

Neves, 2002, Radionuclide production for therapeutic radiopharmaceuticals, Appl. Radiat. Isot., 57, 657, 10.1016/S0969-8043(02)00180-X

O’Brien, 1969, The preparation of 67Cu from 67Zn in a nuclear reactor, Int. J. Appl. Radiat. Isot., 20, 121, 10.1016/0020-708X(69)90149-5

Qaim, 2001, Therapeutic radionuclides and nuclear data, Radiochim. Acta, 89, 297, 10.1524/ract.2001.89.4-5.297

Ramamoorthy, 2002, Production logistics and radionuclidic purity aspects of 153Sm for radionuclide therapy, Nucl. Med. Commun., 23, 83, 10.1097/00006231-200201000-00013

Rogers, 1996, Comparison of bifunctional chelates for radiolabeling monoclonal antibodies with copper radioisotopes, Bioconj. Chem., 7, 511, 10.1021/bc9600372

Sola, 2000, Lutetium-177-EDTMP for bone pain palliation. Preparation, biodistribution, and preclinical studies, Radiochim. Acta, 88, 157, 10.1524/ract.2000.88.3-4.157

Srivastava, 1998, Treatment of metastatic bone pain with tin 117m stannic DTPA, Clin. Cancer Res., 4, 61

Srivastava, 2001, Recent advances in radionuclide therapy, Semin. Nucl. Med., 31, 330, 10.1053/snuc.2001.27043

Stein, 2001, Radioimmunotherapy of a human lung cancer xenograft with monoclonal antibody RS7, J. Nucl. Med., 42, 967

Unni, 2002, Preparation and radiochemical separation of Rh-105 for radiopharmaceutical applications, Radiochim. Acta, 90, 363, 10.1524/ract.2002.90.6.363

Venkatesh, 2001, Complexation studies with 90Y from a novel 90Sr-90Y generator, Radiochim Acta, 89, 413, 10.1524/ract.2001.89.6.413

Volkert, 1999, Therapeutic radiophamaceuticals, Chem. Rev., 99, 2269, 10.1021/cr9804386

Volkert, 1991, Therapeutic radionuclides, J. Nucl. Med., 32, 174

Wessels, 1984, Radionuclide selection and model absorbed dose calculations for radiolabelled tumor associated antibodies, Med. Phys., 11, 638, 10.1118/1.595559